检索结果 - Stenzinger, Albrecht
- Showing 1 - 20 results of 139
- Go to Next Page
-
1
-
2
-
3
CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab 由 Niehr, Franziska, Weichert, Wilko, Stenzinger, Albrecht, Budach, Volker, Tinhofer, Ingeborg
出版 2015Text -
4
-
5
-
6
-
7
-
8
-
9
Protein Tyrosine Phosphatase Interacting Protein 51 (PTPIP51) mRNA Expression and Localization and Its In Vitro Interacting Partner Protein Tyrosine Phosphatase 1B (PTP1B) in Human... 由 Stenzinger, Albrecht, Märker, David, Koch, Philipp, Hoffmann, Jens, Baal, Nelli, Steger, Klaus, Wimmer, Monika
出版 2009Text -
10
-
11
-
12
Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice 由 Faehling, Martin, Schwenk, Birgit, Kramberg, Sebastian, Eckert, Robert, Volckmar, Anna-Lena, Stenzinger, Albrecht, Sträter, Jörn
出版 2017Text -
13
-
14
-
15
SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report 由 Gerber, Tiemo S., Agaimy, Abbas, Hartmann, Arndt, Habekost, Michael, Roth, Wilfried, Stenzinger, Albrecht, Schirmacher, Peter, Straub, Beate K.
出版 2021Text -
16
-
17
TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib 由 Roeper, Julia, Christopoulos, Petros, Falk, Markus, Heukamp, Lukas C., Tiemann, Markus, Stenzinger, Albrecht, Thomas, Michael, Griesinger, Frank
出版 2022Text -
18
-
19
-
20